Complicated Intra-abdominal Infections

• FDA approval · 2025-08-06
  FDA Approved: TIGECYCLINE — Supplemental Application (Apotex Corp)

  FDA approved a supplemental application for tigecycline from Apotex Corp, indicating an approved addition or update under the supplemental f…

• FDA approval · 2020-04-09
  FDA Approved: TIGECYCLINE — Supplemental Application (Sandoz Inc)

  FDA approved Sandoz Inc's supplemental application for tigecycline, a generic antibiotic. This action concerns the ANDA for tigecycline (AND…

• FDA approval · 2019-06-11
  FDA Approved: TIGECYCLINE — Original Application (Eugia US LLC)

  FDA approved the original application for a generic tigecycline product by Eugia US LLC, enabling market availability of a generic tigecycli…

• FDA approval · 2019-03-19
  FDA Approved: ERTAPENEM — Original Application (Apotex Corp)

  FDA approved Apotex Corp's original application for ertapenem sodium (ertapenem), a broad-spectrum carbapenem antibiotic, as a generic produ…

• FDA approval · 2018-12-21
  FDA Approved: TIGECYCLINE — Original Application (Apotex Corp)

  FDA approves Apotex Corp's original application for tigecycline, granting approval of a generic version of the antibiotic.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2018-08-02
  FDA Approved: TIGECYCLINE — Original Application (Amneal Pharmaceuticals LLC)

  FDA approved Amneal Pharmaceuticals LLC's original application for tigecycline, authorizing a generic injectable antibiotic. It covers indic…

• FDA approval · 2007-04-03
  FDA Approved: TYGACIL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

  The FDA approved a supplemental application for TYGACIL (tigecycline) by Wyeth Pharmaceuticals (a Pfizer subsidiary), indicating regulatory …